Is there loss of BRCA1 and increase in 53BP1 in progeria?
Best insight from top research papers
Loss of BRCA1 and an increase in 53BP1 are observed in the context of age-associated DNA repair deficiencies. In aged human mammary epithelial cells, a decrease in the activity of homologous recombination (HR) pathways, including BRCA1, is reported, along with deficient recruitment of 53BP1 to DNA double-strand break sites, leading to a switch to alternative repair mechanisms. Additionally, the inactivation of 53BP1 in BRCA1 mutant cells reduces translesion synthesis (TLS)-specific mutagenesis, indicating a regulatory role of 53BP1 in DNA damage bypass pathways. However, there is no direct mention of the specific relationship between BRCA1 loss and 53BP1 increase in progeria in the provided contexts.
Answers from top 5 papers
More filters
Papers (5) | Insight |
---|---|
Not addressed in the paper. | |
27 Dec 2020 5 Citations | Not addressed in the paper. |
Not addressed in the paper. | |
Not addressed in the paper. | |
Not addressed in the paper. |
Related Questions
Is RIng1b Downregulated in Progeria?5 answersYes, RIng1b is downregulated in progeria. Studies have shown that in Hutchinson-Gilford progeria syndrome (HGPS), the expression of RIng1b is decreased in comparison to normal cells. Additionally, research on Zmpste24-deficient mice, a model for progeria, revealed that impaired insulin-like growth factor 1 receptor (IGF-1R)/Akt signaling leads to premature aging, where progerin interacts with IGF-1R, downregulating its expression and causing cellular senescence. Furthermore, in HGPS, a longitudinal gene expression analysis demonstrated a progressive activation of Rho signaling and SerpinE1, with siRNA-mediated downregulation of SerpinE1 reversing key pathological features of HGPS, indicating its role in the disease. These findings collectively support the downregulation of RIng1b in progeria conditions.
What is the relationship between progeria and alterations in xrcc1 ?5 answersXRCC1 alterations have been linked to various cancers, including glioma, breast cancer, and colorectal cancer, but not specifically to progeria. In glioma, reduced XRCC1 expression was associated with cancer progression, indicating a potential tumor suppressor role. In breast cancer, XRCC1 gene polymorphisms were studied, highlighting its involvement in cancer development. Additionally, XRCC1 polymorphisms were associated with testicular germ cell tumors, affecting genomic instability and tumor progression. In colorectal cancer, XRCC1 alterations were not directly mentioned, but the study focused on chromosomal instability and microsatellite instability as important genetic alterations. However, no direct relationship between XRCC1 alterations and progeria was found in the provided contexts.
How is ku70 changed in progeria cells?5 answersIn progeria cells, Ku70 plays a significant role in DNA repair processes and cellular abnormalities. The presence of progerin, an abnormal lamin A protein, leads to disrupted nuclear architecture, chromatin organization, and gene expression in Hutchinson-Gilford progeria syndrome (HGPS) cells. Additionally, Ku70 is involved in repairing DNA double-strand breaks (DSBs) and is crucial for cellular response to DNA-damaging agents in prostate cancer cells. Moreover, Ku70 is part of the classical nonhomologous end joining (C-NHEJ) repair pathway, where its deficiency can impact the repair of DSBs and lead to cellular abnormalities in G1-phase progenitor B cells. Acetylation of specific lysine residues in the Ku70 nuclear localization signal (NLS) can regulate the subcellular localization of Ku, affecting its function in DNA repair processes.
Is ezh2 upregulated in progeria cells?4 answersEZH2 is not specifically mentioned in the contexts provided in relation to progeria cells. However, the data from the contexts highlights the role of EZH2 in various cancers, such as lung cancer, prostate cancer, and acute myeloid leukemia. EZH2 is implicated in cancer progression, metastasis, and immune infiltration modulation. It is regulated by proteins like USP44 and has prognostic value in different cancer types. While EZH2 is not directly linked to progeria cells in the provided contexts, its involvement in cancer development and progression suggests a potential avenue for exploration in the context of progeria. Further research would be needed to determine if EZH2 is upregulated in progeria cells.
How is xrcc1 regulated in progeria?5 answersXRCC1 regulation in progeria involves various mechanisms. Studies show that XRCC1 plays a crucial role in DNA repair processes. In the context of progeria, dysregulation of XRCC1 can impact DNA repair efficiency, contributing to accelerated aging phenotypes. Specifically, XRCC1 expression can be influenced by factors like PARP1 activity, STAT3 signaling, and epigenetic modifications mediated by KDM5B. These regulatory pathways affect XRCC1 levels and function, potentially leading to impaired DNA repair in progeria. Understanding the intricate regulation of XRCC1 in the context of progeria sheds light on potential therapeutic targets to mitigate the effects of accelerated aging associated with this condition.
Is progerin seen to accumulate in normal aging cells?5 answersProgerin, a truncated form of lamin A, is indeed observed to accumulate not only in Hutchinson-Gilford progeria syndrome (HGPS) but also during normal aging. Studies have shown that progerin accumulation in HGPS patients is caused by LMNA gene mutations. Furthermore, research indicates that progerin accumulation during physiological aging contributes to multiple nuclear abnormalities. In the context of normal aging, progerin has been associated with the accumulation of genomic DNA double-strand breaks, leading to altered DNA repair mechanisms. This suggests that progerin plays a role in both premature aging syndromes like HGPS and in the natural aging process by impacting cellular functions and genomic stability.